A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan

scientific article published on 24 May 2019

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.00124-19
P932PMC publication ID6535569
P698PubMed publication ID30962328

P50authorTeruo KirikaeQ98573411
P2093author name stringMasahiro Shimojima
Hiroki Uchida
Tatsuya Tada
Tomomi Hishinuma
P2860cites workExploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamasesQ36428146
Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico CityQ37672430
Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump InhibitorQ41116821
A general method for detecting and sizing large plasmids.Q45946249
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseQ46862305
Quinolone resistance from a transferable plasmid.Q54143628
Purification development and characterization of the zinc-dependent metallo-β-lactamase from Bacillus anthracisQ83519974
Carbapenemases: the versatile beta-lactamasesQ24685034
Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitorQ27649184
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.Q30726109
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in JapanQ33798129
New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapyQ34192597
Novel VIM metallo-beta-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia.Q34932293
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzymeQ35127937
P433issue6
P921main subjectPseudomonas aeruginosaQ31856
P577publication date2019-05-24
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleA Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan
P478volume63

Search more.